4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-16-020965
President and CEO sold 9,801 shares at $30.00 ($294,030)
- President and CEO acquired 9,801 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pomerantz Roger · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-05-24 | Exercise or conversion : show line 1 in the form | +9,801 | $0.71 | $6,959 | 193,493 | D |
| 2016-05-24 | Sale : show line 2 in the form | −9,801 | $30.00 | $294,030 | 183,692 | D |
| Open-market sales · 9,801 sh · avg $30.00 · $294,030 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-05-24 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −9,801 | $0.71 | 2024-08-07 | 9,801 | 1,362,286 | D |
Loading xslF345X03/doc4.xml…